# A Trial to Evaluate the Effect of Delgocitinib on the Heart Rhythm of Healthy People

> **NCT05050279** · EARLY_PHASE1 · COMPLETED · sponsor: **LEO Pharma** · enrollment: 40 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Delgocitinib capsule
- **DRUG:** Placebo capsule

## Key facts

- **NCT ID:** NCT05050279
- **Lead sponsor:** LEO Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-29
- **Primary completion:** 2022-01-04
- **Final completion:** 2022-01-04
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2026-04-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05050279

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05050279, "A Trial to Evaluate the Effect of Delgocitinib on the Heart Rhythm of Healthy People". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT05050279. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*